CluePoints published part two of a video series with Applied Clinical Trials explaining why time savings turned out to be the single largest driver of financial value in the eNPV model.
Published
Signal category
Research & Knowledge
Quote
“In part two of the video series with Applied Clinical Trials, Sylviane de Viron of CluePoints and Abigail Dirks, MS of Tufts Center for the Study of Drug Development explain why time savings turned out to be the single largest driver of financial value in the eNPV model.”
— CluePoints team
Company
CluePoints
AI-Powered Risk-Based Quality Management (RBQM) & Data Quality Oversight Solutions
- Industry
- Software Development
- Location
- Avenue Albert Einstein 2A, BE
- Company size
- 312 employees
CluePoints is the premier provider of RBQM and data quality oversight software. We’re leveraging the potential of AI using advanced statistics and ML to determine the quality, accuracy, and integrity of clinical trial data both during and after the study. Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy. Coupled with thought leadership and consulting expertise to aid risk assessment and solution implementation, the result is positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM. To learn more about CluePoints, visit CluePoints.com.
Founded 2012